logo
Products
Services
Resources
Selection Guides
About
iFluor® 488 Anti-human/ dog CD132 Antibody
TUGh4
The TUGh4 monoclonal antibody binds to human/ dog CD132, a 64 - 70 kD member of the Ig superfamily frequently located on the surface of macrophages and B cells. CD132 is a component of important cellular pathways, namely, the interleukin-21-mediated signaling pathway, interleukin-9-mediated signaling pathway and interleukin-2-mediated signaling pathway. In addition, in certain organisms, it is an enhancer of phagocytosis. From a research standpoint, it is of biological interest due to its association with important macromolecules/ligands such as CD124, JAK1, CD25 and lck. CD132 is a relatively rare antibody target, with fewer than 800 publications in the last decade. Even still, CD132 has a variety of applications in immunology research, frequently serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to iFluor® 488 (ex/em = 491/516 nm). It is compatible with the 488 nm laser and 512/18 nm bandpass filter (for example, as in the Luminex Guava easyCyte).
product image
product image
CatalogSize
Price
Quantity
11320050100 tests
Price
11320051500 tests
Price
 
Antibody properties

Other namesCommon γ chain
CloneTUGh4
HostRat
IsotypeIgG2b, kappa
ReactivityHuman, Dog
ApplicationFlow Cytometry (FACS), Fluorescence Imaging
Spectral properties

Correction factor (260 nm)0.21
Correction factor (280 nm)0.11
Extinction coefficient (cm -1 M -1)
75000
1
Excitation (nm)491
Emission (nm)516
Quantum yield
0.9
1
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on April 4, 2026